Journal of Glaucoma最新文献

{"title":"One-Year Outcomes of Gonio Scratch as a Minimally Invasive Glaucoma Surgery with Cataract Removal.","authors":"Kana Tokumo, Mitsunobu Yokoyama, Taro Baba, Naoki Okada, Ayaka Edo, Kaori Komatsu, Hideaki Okumichi, Hideki Mochizuki, Teruyuki Miyoshi, Yoshiaki Kiuchi, Kazuyuki Hirooka","doi":"10.1097/IJG.0000000000002563","DOIUrl":"https://doi.org/10.1097/IJG.0000000000002563","url":null,"abstract":"<p><strong>Prcis: </strong>This study evaluated the 1-year efficacy and safety of a novel minimally invasive glaucoma surgery, gonio scratch, in reducing intraocular pressure of eyes with open-angle glaucoma and cataracts.</p><p><strong>Purpose: </strong>To evaluate the 1-year efficacy and safety of phacoemulsification cataract extraction combined with gonio scratch (GS-Phaco), a novel minimally invasive glaucoma surgery, in patients with open-angle glaucoma and cataracts.</p><p><strong>Patients and methods: </strong>This prospective multicenter clinical trial was conducted at Hiroshima University, Yokoyama Retina Clinic, Kusatsu Eye Clinic, and Miyoshi Eye Clinic in Japan. The primary outcome measure was the rate of intraocular pressure (IOP) control. Failure was defined as an IOP of >18 mmHg or >14 mmHg, a <20% reduction from baseline IOP on two consecutive follow-up visits after 3 months, the need for additional glaucoma surgery, or loss of light perception. Kaplan-Meier analysis was used to assess surgical success rates.</p><p><strong>Results: </strong>Forty-seven eyes of 47 patients who underwent GS-Phaco surgery were included in the analysis. None of the patients had undergone prior ocular surgery. The median baseline IOP was 17 mmHg. At 12 months postoperatively, there was a significant reduction in IOP to a median of 12 mmHg (P<0.01). The number of glaucoma medications also decreased significantly, from a median of two to one (P<0.01). The surgical success rate at 12 months was 80.9%. The only complication observed was transient elevation of IOP in two (4.3%) eyes. No patients developed anterior chamber hemorrhage or hyphema with niveau formation.</p><p><strong>Conclusion: </strong>GS-Phaco achieved sustained IOP reduction and a decrease in medication use at 12 months postoperatively in patients with open-angle glaucoma and cataracts.</p>","PeriodicalId":15938,"journal":{"name":"Journal of Glaucoma","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143605174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison between Phacoemulsification-iStent Inject W and Phacoemulsification-Micropulse Transscleral Laser Therapy in Asian Eyes with Mild-Moderate Open Angle Glaucoma.","authors":"Michel Marco Figueras, Naoki Okada, Chai Keong Tan, Maria Cecilia Aquino, Marcus Chun Jin Tan, Katherine Wanxian Lun, Dawn Ka Ann Lim, Seng Chee Loon, Paul Tec Kuan Chew, Victor Teck Chang Koh","doi":"10.1097/IJG.0000000000002564","DOIUrl":"https://doi.org/10.1097/IJG.0000000000002564","url":null,"abstract":"<p><strong>Prcis: </strong>In this retrospective cohort study, the 1-year cumulative probability of failure was comparable, achieving 52.20% in the phacoemulsification-iStent inject W (phaco/iStent) group and 47.80% in the phacoemulsification-micropulse transscleral laser therapy (phaco/MPTLT) group (P=0.994).</p><p><strong>Purpose: </strong>To compare the 1-year efficacy and safety of phacoemulsification combined with iStent Inject W (phaco/iStent) and phacoemulsification combined with micropulse transscleral laser therapy (phaco/MPTLT).</p><p><strong>Methods: </strong>Retrospective cohort study that included patients with mild-moderate open angle glaucoma (OAG) and cataract who underwent either phaco/iStent or phaco/MPTLT in a tertiary hospital in Singapore between August 1, 2016 and December 31, 2022. The primary outcome measures were cumulative probabilities of failure between the two groups with failure defined as disease progression by Ocular Coherence Tomography (OCT-RNFL) or Visual Field Test (VFT), repeat glaucoma surgery, and inability to maintain intraocular pressure (IOP) lower than pre-operative baseline or the use of glaucoma medications for 2 consecutive visits after 1 month post-operatively. Additionally, post-operative mean IOP, average number of IOP lowering medications, visual acuity, and complications were analyzed.</p><p><strong>Results: </strong>Forty-six patients were included. 23 eyes underwent phaco/iStent and 23 had phaco/MPTLT. The two groups had comparable cumulative probabilities of failure (52.20% phaco/iStent, 47.80% phaco/MPTLT; P=0.994) and mean IOP (15.57+2.95 mmHg phaco /iStent, 14.39+2.25 mmHg phaco/MPTLT; P=0.136) after 1 year. The change in IOP before surgery to 12 months is -1.04+3.07 mmHg in the phaco/iStent group (P=0.593) and -2.43+4.12 mmHg in the phaco/MPTLT group (P=0.022). Both achieved significant medication reduction burden (P<0.05). Intra-operative and post-operative complication rates were similar.</p><p><strong>Conclusion: </strong>Both groups showed comparable surgical efficacy and safety after 1 year. The phaco/MPTLT group demonstrated sustained IOP reduction 1 year post-operatively.</p>","PeriodicalId":15938,"journal":{"name":"Journal of Glaucoma","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143605170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pattern of Long Term Intraocular Pressure Variation following Gonioscopy-assisted Transluminal Trabeculotomy: Two-year Outcomes.","authors":"Bruno M Faria, Diego T Dias, Mariana A O Reis, Fabio B Daga, Ana L B Scoralick, Leopoldo Magacho, Pedro H E Ribeiro Junior, Fabio N Kanadani, Vital P Costa, Tiago S Prata","doi":"10.1097/IJG.0000000000002565","DOIUrl":"https://doi.org/10.1097/IJG.0000000000002565","url":null,"abstract":"<p><strong>Prcis: </strong>Patients with clinically uncontrolled open-angle glaucoma submitted to isolated gonioscopy-assisted transluminal trabeculotomy or combined with phacoemulsification not only achieved low mean IOPs, but also demonstrated stable IOP patterns during a 24-month follow-up.</p><p><strong>Purpose: </strong>To assess the impact of gonioscopy-assisted transluminal trabeculotomy (GATT) on long term intraocular pressure (IOP) variation.</p><p><strong>Patients and methods: </strong>An unicentric retrospective study including 169 consecutive patients who had undergone standalone GATT or combined with phacoemulsification (PHACOGATT) due to clinically uncontrolled open-angle glaucoma, with at least 12 months of follow-up was conducted. Long term mean IOP, long term IOP peak, long term IOP fluctuation, coefficient of variation, mean-positive IOP variation, sustained clinically significant positive IOP variation and number of follow-up visits with IOP ≥15 mmHg were investigated.</p><p><strong>Results: </strong>169 eyes from 169 patients were included (GATT group=101 patients; PHACOGATT group=68 patients). Mean long term IOP (12.0±1.8 vs. 11.2±2.0 mmHg), mean long term IOP peak (12.9±2.6 vs. 11.8±3.5 mmHg) and mean coefficient of variation (0.07±0.08 vs. 0.05±0.09) were lower in the PHACOGATT group, while mean IOP fluctuation (1.0±3.7 mmHg vs. 1.2±1.8 mmHg) was lower in the GATT group. Additionally, overall mean-positive IOP variation was 0.79±1.64 mmHg. Finally, only 6.5% of the patients presented sustained clinically significant positive IOP variation and IOP was ≥15 mmHg in 5.9% of the follow-up visits.</p><p><strong>Conclusions: </strong>Patients with clinically uncontrolled open-angle glaucoma submitted to GATT or PHACOGATT achieved low mean IOPs and demonstrated stable IOP patterns. Our results provide additional evidence supporting GATT and PHACOGATT as viable options for the treatment of medically uncontrolled glaucoma patients requiring low and stable IOPs.</p>","PeriodicalId":15938,"journal":{"name":"Journal of Glaucoma","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143605176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Social Vulnerability Associated with Frequency of Visual Field and Optical Coherence Tomography Testing in Glaucoma Patients.","authors":"Daniel X Chen, Hannah Hashimi, Leona Ding, Karine D Bojikian, Andrew Chen","doi":"10.1097/IJG.0000000000002532","DOIUrl":"https://doi.org/10.1097/IJG.0000000000002532","url":null,"abstract":"<p><strong>Precis: </strong>Higher Social Vulnerability Index scores, limited-English proficiency and retirement/disability status were associated with lower odds of completing one visual field and optical coherence tomography/year in glaucoma patients.</p><p><strong>Purpose: </strong>To assess the correlation between sociodemographic factors and the Social Vulnerability Index to the likelihood of not receiving one visual field testing and one retinal nerve fiber layer optical coherence tomography test per year.</p><p><strong>Methods: </strong>Patient records with glaucoma living in Washington state from a single academic institution (2014-2021) were reviewed. Those with a single visit, an address with no Social Vulnerability Index score, or a diagnosis relating to pre-glaucoma, glaucoma-suspect, or ocular hypertension were excluded. Demographic data, Social Vulnerability Index scores, and the number of visual fields and optical coherence tomography were collected. Patients were classified as meeting testing criteria if they had at least one visual field and optical coherence tomography per year. Logistic regression was used to assess if sociodemographic factors and Social Vulnerability Index scores were associated with not meeting testing criteria.</p><p><strong>Results: </strong>3,971 patients were included: 1,470 (37.0%), 1,834 (46.2%), and 1,413 (35.6%), had at least 1 visual field/year, at least 1 optical coherence tomography/year, and at least 1 visual field and 1 optical coherence tomography/year, respectively. On average 0.8±0.6 visual field/year and 0.9±0.6 optical coherence tomography/year were performed. Limited English proficiency (P=0.009), being disabled/retired (P=0.003), and higher Social Vulnerability Index scores (P<0.001) were associated with higher odds of not meeting testing criteria.</p><p><strong>Conclusions: </strong>While higher Social Vulnerability Index scores were linked to reduced odds of glaucoma testing, specific sociodemographic factors - such as limited English proficiency and retirement/disability - further reduced the odds.</p>","PeriodicalId":15938,"journal":{"name":"Journal of Glaucoma","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143605178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Telemedicine in Glaucoma Management: Patient Perspectives.","authors":"Angela J Oh, Ella Bouris, Brayden K Leyva, Mashal Malik, Joseph Caprioli","doi":"10.1097/IJG.0000000000002558","DOIUrl":"https://doi.org/10.1097/IJG.0000000000002558","url":null,"abstract":"<p><strong>Prcis: </strong>Patient satisfaction and perspectives on telemedicine for glaucoma are crucial for validating the efficacy of remote healthcare. This study underscores its acceptance by patients in a single academic practice.</p><p><strong>Purpose: </strong>To evaluate patient satisfaction and preferences with telemedicine visits integrated into a glaucoma practice.</p><p><strong>Methods: </strong>A prospective observational study of patients of a single glaucoma specialist's telemedicine practice was performed using an online questionnaire.</p><p><strong>Results: </strong>Of the 219 patients contacted, 153 (69%, mean age 67.0 y, 58% women) completed the survey. 68% had glaucoma (43% mild, 44% moderate, and 13% severe) and 32% were glaucoma suspects. Patients had been under the care of the specialist for 10±6.2 years, with 41% having undergone surgery with the specialist. The mean number of prior office visits with the specialist was 9.7±6.3 (range 1-24 y) with an average of 0.8 (range 0-3) prior telemedicine visits at the time of the survey. 97% reported satisfaction with integrated telehealth visits, and 78% would recommend telemedicine visits. 93% planned to continue with telemedicine; five patients (3%) requested switching to in-person only visits with another provider. Compared to their in-person visits, patients found integrated telemedicine visits less time consuming and more convenient.</p><p><strong>Conclusions: </strong>This study demonstrates high satisfaction and support for integrated telemedicine visits among glaucoma patients within a specialized practice setting.</p>","PeriodicalId":15938,"journal":{"name":"Journal of Glaucoma","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143542235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Intraocular Pressure Measurements With the Tono-Vera®, a new Handheld Rebound Tonometer.","authors":"Luiz A F Beniz, Alessandro A Jammal, Davina A Malek, Henry Tseng, Felipe A Medeiros","doi":"10.1097/IJG.0000000000002556","DOIUrl":"https://doi.org/10.1097/IJG.0000000000002556","url":null,"abstract":"<p><strong>Prcis: </strong>In a cross-sectional study comparing the novel Tono-Vera handheld rebound tonometer with the Ocular Response Analyzer, strong agreement was found between intraocular pressure measurements of the two devices.</p><p><strong>Purpose: </strong>To compare intraocular pressure (IOP) measurements obtained by the new Tono-Vera (Reichert Technologies, Depew, NY), a novel handheld rebound tonometer with proprietary camera-based positioning system, with those from the Ocular Response Analyzer (ORA, Reichert Technologies, Depew, NY) non-contact tonometer.</p><p><strong>Patients: </strong>54 eyes of normal individuals and open-angle glaucoma subjects.</p><p><strong>Methods: </strong>All subjects had at least 6 reliable measurements with the Tono-Vera and 3 with the ORA, acquired by the same technician in the same visit. The sample was randomly split into calibration and validation samples. An ordinary least squares linear regression model generated a calibration formula for Tono-Vera readings using ORA's Goldmann-correlated IOP (IOPg) as target. Bland-Altman plots evaluated agreement between Tono-Vera calibrated IOP (IOPtv) and ORA IOPg in the validation sample.</p><p><strong>Main outcome measures: </strong>Agreement between IOPtv and IOPg measurements.</p><p><strong>Results: </strong>50 glaucoma and 4 normal eyes were included, mean age 68.3 ± 9.4 years, mean central corneal thickness 535.0 ± 39.6 μm. In the validation sample, mean IOPtv was 14.6 ± 5.2 mmHg (range, 7.4-28.5 mmHg) versus 15.0 ± 5.3 mmHg (range, 6.6-28.6 mmHg) for ORA IOPg (R² = 0.782). Bland-Altman plots showed mean difference of -0.4 ± 2.5 mmHg (95% limits of agreement: -5.4 to 4.5 mmHg). 58.6%, 79.3%, and 96.5% of IOPtv measurements fell within ± 2, ± 3, and ± 5 mmHg of ORA measurements. No fixed or proportional biases were observed (P = 0.620).</p><p><strong>Conclusion: </strong>There was strong correlation and agreement in IOP measurements between calibrated Tono-Vera IOP and ORA IOPg.</p>","PeriodicalId":15938,"journal":{"name":"Journal of Glaucoma","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143542233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Development of a Computerized and Automated Cost-Effectiveness Analysis Application to Aid in Glaucoma Surgical Management.","authors":"Jaideep Prasad, Shefali Sood, Lama A Al-Aswad","doi":"10.1097/IJG.0000000000002557","DOIUrl":"https://doi.org/10.1097/IJG.0000000000002557","url":null,"abstract":"<p><strong>Precise: </strong>In this article, we describe the development of validated software that automates cost-effectiveness analyses of minimally invasive glaucoma surgeries based on modifications to robust mathematical models of glaucoma progression and management discussed in previous literature.</p><p><strong>Purpose: </strong>To develop a validated application to streamline use of cost-effectiveness (CE) in clinical management and investigations of minimally invasive glaucoma surgeries (MIGS) in the United States.</p><p><strong>Design: </strong>Automated cost-utility analysis adapted from Markov models described in prior literature.</p><p><strong>Participants: </strong>Patients of ages 65 years and greater with mild to moderate primary open-angle glaucoma irrespective of concurrent visually significant cataract.</p><p><strong>Methods: </strong>Markov models simulating glaucoma progression through 37 states and death were constructed based on previous CE models of minimally invasive trabecular meshwork stents. These states represent combinations of various glaucoma severity (mild, moderate, advanced, and severe/blind) with differences in clinical management, including use of up to 4 medications, selective laser trabeculoplasty, or incisional surgery. These are not mutually exclusive and are based on decisions related to the rate of thinning of the retinal nerve fiber layer. Rather than using fixed sets of transition probabilities for specific surgical interventions, new transition probabilities are dynamically derived based on the expected reduction in intraocular pressure related to visual field mean deviation decline. In addition to the generic MIGS arm, two comparison arms (cataract-surgery or medications-only) are included. Medication reduction, whole costs, and utilities are modifiable inputs in the model. Optimal and worst-case results are determined by uncomplicated or complicated (secondary surgical intervention required/medication nonadherence) intervention outcomes. The model was entirely re-implemented in R and validated by comparing results to TreeAge data.</p><p><strong>Main outcome measures: </strong>Total costs, quality adjusted life years (QALY), and incremental cost-effectiveness ratio (ICER).</p><p><strong>Results: </strong>An optimal-case 35-year CE-analysis of the implantation of Hydrus and iStent inject devices provided values of costs and QALY that were similar to prior data (R vs. TreeAge): Hydrus (Cost: $50446.53 vs. $48026.13; QALY: 12.18 vs. 12.26), iStent inject (Cost: $52323.43 vs. $49599.86; QALY: 12.13 vs. 12.21), cataract (Cost: $54150.56 vs. $54409.25; QALY: 12.03 vs. 12.04). Trends of ICER over time were also very similar.</p><p><strong>Conclusions: </strong>Novel software is available to aid in CE analyses of MIGS with modifiable inputs and outcomes of interest. Such a tool makes CE more accessible for use in clinical management decisions and may guide future investigation.</p>","PeriodicalId":15938,"journal":{"name":"Journal of Glaucoma","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143542231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Treatment Outcomes of Micropulse Transscleral Laser Therapy as an Adjunctive Therapy in African American Individuals with Prior Procedural Interventions.","authors":"Anna Dickinson, Luke Leidy, Jella An, Mona Kaleem, Aleksandra Mihailovic, Constance Okeke","doi":"10.1097/IJG.0000000000002559","DOIUrl":"https://doi.org/10.1097/IJG.0000000000002559","url":null,"abstract":"<p><strong>Prcis: </strong>Micropulse transscleral laser therapy is a clinically beneficial adjunctive treatment option for African American individuals with severe-stage primary open-angle glaucoma who have undergone prior glaucoma procedural interventions.</p><p><strong>Purpose: </strong>To assess the safety and efficacy of micropulse transscleral laser therapy as an adjunctive treatment in reducing intraocular pressure and ocular hypotensive medications in African American patients.</p><p><strong>Methods: </strong>We analyzed forty-four eyes of 44 African American individuals with severe-stage primary open-angle glaucoma which underwent prior procedural interventions and received a subsequent micropulse treatment. Mean intraocular pressure and ocular hypotensive medications were evaluated at all postoperative visits through 12 months. Main outcome measures included within-group reductions in intraocular pressure and ocular hypotensive medications at 12 months compared to baseline. Univariate and multivariable logistic regression models were used to calculate odds ratios to evaluate characteristics associated with the likelihood of success at 12 months. Success was defined as achieving a target intraocular pressure of ≤12 mmHg without additional medications and no secondary surgical interventions.</p><p><strong>Results: </strong>Mean intraocular pressure was significantly reduced from 22.9±6.2 mmHg at baseline to 13.8±4.8 at 12 months following micropulse, a 40% reduction (P<0.001). The majority of patients were on 4-6 ocular hypotensive medications at baseline. By 12 months, the proportion of patients requiring ≥3 ocular hypotensive medications was significantly reduced compared to baseline (P=0.03). Univariate analysis revealed that a history of trabeculectomy before micropulse treatment increased the likelihood of successful surgery at 12 months by nearly 5-fold (OR, 4.67; P=0.03).</p><p><strong>Conclusion: </strong>Micropulse is an effective adjunctive treatment in African Americans with severe-stage primary open-angle glaucoma and a history of prior glaucoma procedures.</p>","PeriodicalId":15938,"journal":{"name":"Journal of Glaucoma","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143542236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association Between Risk of Obstructive Sleep Apnea and Intraocular Pressure Based on the Korea National Health and Nutrition Examination Survey VIII.","authors":"Jung Lim Kim, Kayoung Lee","doi":"10.1097/IJG.0000000000002512","DOIUrl":"10.1097/IJG.0000000000002512","url":null,"abstract":"<p><strong>Prcis: </strong>A higher screening tool for obstructive sleep apnea risk (STOP-BANG) score and loud snoring observed breathing interruptions during sleep, hypertension, and wide neck circumference (NC) were individually and in combination associated with high intraocular pressure (IOP) in Koreans aged 40 years and older.</p><p><strong>Objective: </strong>To evaluate the relationship between IOP and the risk of obstructive sleep apnea (OSA).</p><p><strong>Methods: </strong>In this population-based, cross-sectional study, we included Korean adults aged 40 years or above recruited between 2019 and 2021. A total of 6315 subjects were included in the Korea National Health and Nutrition Examination Survey Ⅷ database. The risk of OSA was measured by the STOP-BANG questionnaire. The IOPs were measured using a rebound tonometer. Logistic regression was used to analyze the association between IOP quartiles (highest quartile vs lower first to third quartiles) with OSA risk after adjusting for sociodemographic characteristics, lifestyle, and diabetes.</p><p><strong>Results: </strong>The adjusted odds ratio for high IOP was 1.27 (95% CI: 1.12-1.43) for participants with a STOP-BANG score of 3-8 compared with those with a score of 0-2. Participants with loud snoring observed breathing interruptions during sleep, hypertension, or wide NC had 24%-40% higher odds of high IOP than those without these components. The odds ratio for high IOP in the group with all 4 factors was 2.09 times higher (95% CI: 1.26-3.46) than in the group without these factors.</p><p><strong>Conclusions: </strong>A higher STOP-BANG score was associated with an increased risk of high IOP in Koreans aged 40 years and older. Furthermore, among the STOP-BANG components, loud snoring observed breathing interruptions during sleep, hypertension, and wide NC were individually and in combination associated with high IOP.</p>","PeriodicalId":15938,"journal":{"name":"Journal of Glaucoma","volume":" ","pages":"151-156"},"PeriodicalIF":2.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142522061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of Elisar-Fast and Sita-Fast Strategies for Visual Field Assessment in Glaucoma.","authors":"Priya Narang, Fareya Fatheema Rasheed, Amar Agarwal, Rhea Narang, Ashvin Agarwal","doi":"10.1097/IJG.0000000000002505","DOIUrl":"10.1097/IJG.0000000000002505","url":null,"abstract":"<p><strong>Prcis: </strong>The study documents the ability of Elisar-Fast to successfully assess visual field in patients with glaucoma.</p><p><strong>Purpose: </strong>To compare 2 fast threshold strategies of visual field assessment: SITA-Fast (SF; Humphrey field analyser) and Elisar-Fast (EF; advanced vision analyser) in patients with glaucoma.</p><p><strong>Methods: </strong>In this cross-sectional observational study, of total 192 subjects, 138 subjects (150 eyes, 80 glaucoma subjects [91 eyes] and 58 healthy controls [59 eyes]) were analysed and included. Each subject underwent 24-2 EF and SF in randomized order with a minimum time interval of 1 hour between tests.</p><p><strong>Main outcome measures: </strong>Mean test-time, pointwise and sectoral sensitivity, significance of values of mean sensitivity (MS) and global indices (mean deviation [MD] and pattern SD [PSD]) and their correlation.</p><p><strong>Results: </strong>The mean test-time was 2.59±0.25 and 3.38±0.28 minutes ( P = 0.001) with SF and EF, respectively. Correlation coefficient for pointwise threshold values correlated strongly for both devices (range, 0.70-0.92). The intraclass correlation value of ≥0.8 was observed across all sectors, indicating good reliability. Bland-Altman plot denoted 95% of the data for MS values within limit of agreement. The intraclass correlation values for overall MS, MD, and PSD were 0.916, 0.913, and 0.872, respectively, indicating good reliability. High degree of correlation was observed for MD (r=0.912, P =0.00) and PSD values (r=0.732, P =0.00). Comparison of values indicated a difference of 1.09 dB for MD and 0.06 dB for PSD between both strategies.</p><p><strong>Conclusions: </strong>A high degree of correlation existed between the global indices and pointwise threshold values. The study documents the ability of EF to successfully assess visual field in patients with glaucoma.</p>","PeriodicalId":15938,"journal":{"name":"Journal of Glaucoma","volume":" ","pages":"198-204"},"PeriodicalIF":2.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142348145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}